Armata Pharmaceuticals (ARMP) Cash from Operations (2013 - 2026)

Armata Pharmaceuticals (ARMP) has 14 years of Cash from Operations data on file, last reported at 5782000.0 in Q1 2026.

• For the quarter ending Q1 2026, Cash from Operations rose 23.72% year-over-year to 5782000.0; the trailing twelve-month figure through Mar 2026 stood at 23965000.0 (up 30.63% YoY), and the FY2025 full-year result was 25763000.0, up 31.39% from the prior year.
• Cash from Operations advanced to 5782000.0 in Q1 2026, from 6674000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 3515000.0 in Q1 2022 to a low of 17570000.0 in Q1 2023.
• A 5-year average of 8764705.88 and a median of 8148000.0 in 2022 frame the typical range for Cash from Operations.
• Across the five-year window, Cash from Operations plunged 399.86% in 2023 and jumped 51.51% in 2025, its largest moves.
• Tracing ARMP's Cash from Operations over 5 years: stood at 10485000.0 in 2022, then grew by 22.69% to 8106000.0 in 2023, then gained by 2.21% to 7927000.0 in 2024, then gained by 15.81% to 6674000.0 in 2025, then grew by 13.37% to 5782000.0 in 2026.
• Business Quant data shows ARMP's Cash from Operations at 5782000.0 in Q1 2026, 6674000.0 in Q4 2025, and 4298000.0 in Q3 2025.